Innovating Works

PATH-TOX

financed
JANSSEN PHARMACEUTICA NV
134.53K€ | Leader
VOSSLOH ESPANA
295.80K€ | participant
PDS
293.13K€ | participant
DECIPHEX LIMITED
1.63M€ | participant